Combining incretin-based therapies with insulin: realizing the potential in type 2 diabetes. Diabetes Care 2013;36(Suppl. 2):S226–S232

Por Vora, J
Publicado em 2013

Use of glucagon‐like peptide‐1 receptor agonists among individuals on basal insulin requiring treatment intensification

Por Trautmann, M. E., Vora, J.
Publicado no Diabet Med (2018)

Effects of cabergoline in a pituitary adenoma secreting follicle-stimulating hormone.

Por Leese, G., Jeffreys, R., Vora, J.
Publicado em 1997

Adult Traumatic Inferior Hip Dislocation: Rare Case Ended with Open Reduction

Por Ismael, Salam, Vora, J, Thomas, P
Publicado no J Orthop Case Rep (2017)

Parathyroid hormone related protein (PTHrP) in hypercalcaemia of lymphoproliferative disease.

Por Davies, S V, Vora, J, Wardrop, C A
Publicado em 1993

Screening for diabetic retinopathy. Approaching 90% sensitivity with new techniques.

Por Leese, G., Broadbent, D., Harding, S., Vora, J.
Publicado em 1995

Screening for sight threatening eye disease

Por Harding, S P, Broadbent, D M, Vora, J P
Publicado em 1996

Screening for diabetic retinopathy

Por Ryder, R E J, Vora, J, Hayes, T M, Young, S
Publicado em 1985

Suppurative thyroiditis with oesophageal carcinoma.

Por Premawardhana, L. D., Vora, J. P., Scanlon, M. F.
Publicado em 1992

Diagnostic difficulties in periodic Cushing's syndrome.

Por Walker, A. B., Leese, G. P., Vora, J. P.
Publicado em 1997

The influence of aprotinin on regional absorption of soluble human insulin.

Por Owens, D R, Vora, J P, Birtwell, J, Luzio, S, Hayes, T M
Publicado em 1988

A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations

Por Evans, M, Schumm-Draeger, P M, Vora, J, King, A B
Publicado em 2011

Insulin degludec does not increase antibody formation versus insulin glargine: an evaluation of phase IIIa trials

Por Vora, J., Seufert, J., Solberg, H., Kinduryte, O., Johansen, T., Hollander, P.
Publicado no Diabetes Obes Metab (2016)

The diabetic patient with hypertension.

Por Leese, G. P., Savage, M. W., Chattington, P. D., Vora, J. P.
Publicado em 1996

Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study.

Por Harding, S. P., Broadbent, D. M., Neoh, C., White, M. C., Vora, J.
Publicado em 1995

Effect of somatostatin on renal function.

Por Vora, J P, Owens, D R, Ryder, R, Atiea, J, Luzio, S, Hayes, T M
Publicado em 1986

Non-mydriatic photography and diabetic retinopathy: Authors' reply

Por Jones, Dylan, Dolben, John, Owens, David, Vora, J, Young, Steve, Creagh, F N
Publicado em 1988

The metabolic response to glucagon and glucagon-(1-21)-peptide in normal subjects and non insulin dependent diabetics.

Por Owens, D R, Vora, J, Morris, T, Luzio, S, Ryder, R E, Atiea, J, Hayes, T M
Publicado em 1986

A case of hereditary combined deficiency of complement components C6 and C7 in man.

Por Morgan, B P, Vora, J P, Bennett, A J, Thomas, J P, Matthews, N
Publicado em 1989

Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours

Por Nwosu, A C, Jones, L, Vora, J, Poston, G J, Vinjamuri, S, Pritchard, D M
Publicado em 2008